MDA 2023 symposium: Integrating corticosteroids into all-around Duchenne muscular dystrophy care
The PTC Therapeutics symposium at MDA 2023 focused on all-around care for Duchenne muscular dystrophy (DMD). This symposium detailed how corticosteroids can be integrated into all-around DMD care
Explore long-term and real-world outcomes of corticosteroids for treating DMD Learn about how delaying DMD milestones can impact patients and caregivers Discover how early and continuous corticosteroid can impact disease milestones in both ambulatory and non-ambulatory patients with DMD
This symposium was developed and funded by PTC Therapeutics for MDA 2023.
Register now to unlock the content
Register now to access the content on this page
If not, register below
MED-ALL-DMD-2300080 | August 2023
Close Register here to access the content on the site MED-ALL-CORP-2200029 | October 2023
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our
Privacy Statement and our Terms and Conditions do not apply.
MED-ALL-CORP-2200029 | October 2023
Close COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available,